These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 10334818)
1. Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Siragy HM; Carey RM Hypertension; 1999 May; 33(5):1237-42. PubMed ID: 10334818 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. Tsutsumi Y; Matsubara H; Masaki H; Kurihara H; Murasawa S; Takai S; Miyazaki M; Nozawa Y; Ozono R; Nakagawa K; Miwa T; Kawada N; Mori Y; Shibasaki Y; Tanaka Y; Fujiyama S; Koyama Y; Fujiyama A; Takahashi H; Iwasaka T J Clin Invest; 1999 Oct; 104(7):925-35. PubMed ID: 10510333 [TBL] [Abstract][Full Text] [Related]
3. The subtype 2 of angiotensin II receptors and pressure-natriuresis in adult rat kidneys. Liu KL; Lo M; Grouzmann E; Mutter M; Sassard J Br J Pharmacol; 1999 Feb; 126(3):826-32. PubMed ID: 10188997 [TBL] [Abstract][Full Text] [Related]
4. A nonpeptide angiotensin II type 2 receptor agonist prevents renal inflammation in early diabetes. Matavelli LC; Zatz R; Siragy HM J Cardiovasc Pharmacol; 2015 Apr; 65(4):371-6. PubMed ID: 25590749 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive and Antioxidant Effects of an Aqueous Extract of Asafetida in Renovascular Hypertensive Rats. Kazemi F; Mohebbati R; Shafei MN Saudi J Kidney Dis Transpl; 2023 Dec; 34(Suppl 1):S86-S95. PubMed ID: 38995276 [TBL] [Abstract][Full Text] [Related]
7. Renal vascular responses to angiotensin II infusion in two kidneys-one clip hypertensive rats under partial ischemia/reperfusion with and without ischemia preconditioning: the roles of AT1R blockade and co-blockades of AT1R and MasR. Karimi F; Nematbakhsh M Res Pharm Sci; 2023; 18(4):392-403. PubMed ID: 37614612 [TBL] [Abstract][Full Text] [Related]
9. Up-Date on Diabetic Nephropathy. Pelle MC; Provenzano M; Busutti M; Porcu CV; Zaffina I; Stanga L; Arturi F Life (Basel); 2022 Aug; 12(8):. PubMed ID: 36013381 [TBL] [Abstract][Full Text] [Related]
10. The Na Nwia SM; Li XC; Leite APO; Hassan R; Zhuo JL Front Physiol; 2022; 13():861659. PubMed ID: 35514347 [TBL] [Abstract][Full Text] [Related]
11. Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation. Bekassy Z; Lopatko Fagerström I; Bader M; Karpman D Nat Rev Immunol; 2022 Jul; 22(7):411-428. PubMed ID: 34759348 [TBL] [Abstract][Full Text] [Related]
12. Smoking cessation avatar-led Acceptance and Commitment Therapy digital intervention: feasibility and acceptability in young adults. Karekla M; Savvides SN Transl Behav Med; 2021 Feb; 11(1):198-205. PubMed ID: 31628476 [TBL] [Abstract][Full Text] [Related]
13. Independent regulation of renin-angiotensin-aldosterone system in the kidney. Nishiyama A; Kobori H Clin Exp Nephrol; 2018 Dec; 22(6):1231-1239. PubMed ID: 29600408 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide in the kidney : its physiological role and pathophysiological implications. Lee J Electrolyte Blood Press; 2008 Jun; 6(1):27-34. PubMed ID: 24459519 [TBL] [Abstract][Full Text] [Related]
18. Nonclassical renin-angiotensin system and renal function. Chappell MC Compr Physiol; 2012 Oct; 2(4):2733-52. PubMed ID: 23720263 [TBL] [Abstract][Full Text] [Related]
20. Influence of Fimasartan (a Novel AT(1) Receptor Blocker) on Catecholamine Release in the Adrenal Medulla of Spontaneously Hypertensive Rats. Lim HJ; Lee SK; Lim DY Korean J Physiol Pharmacol; 2013 Feb; 17(1):99-109. PubMed ID: 23441003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]